Cellular Proliferation: UBP12 restricts the activity of latent proteases DA1, DAR1, and DAR2 by removing ubiquitin chains, preventing excessive proteolysis and maintaining organ size . Overexpression of UBP12 delays endoreduplication, reducing cell ploidy levels (e.g., fewer 8C nuclei in leaves) .
Hormone Signaling:
Brassinosteroid (BR) Signaling: UBP12 stabilizes BRI1 (BR receptor) by removing K63-linked ubiquitin, preventing vacuolar degradation. ubp12i/ubp13 mutants exhibit dwarfism and BR insensitivity .
Abscisic Acid (ABA) Signaling: UBP12 deubiquitinates VPS23A (ESCRT-I component), modulating ABA receptor PYL4 trafficking and drought tolerance .
UBP12 interacts with GIGANTEA (GI) and stabilizes ZTL (Zinc-finger CCT domain-containing protein), a key regulator of photoperiodic flowering. ubp12i/ubp13 mutants show delayed flowering and disrupted circadian rhythms, with reduced ZTL protein levels .
While specific antibody products are not detailed in literature, antibodies targeting UBP12 are likely used in:
Immunoprecipitation (IP): To isolate UBP12 and its interactors (e.g., DA1, BRI1, VPS23A) .
Western Blotting: To quantify UBP12 protein levels in wild-type vs. mutant plants .
Subcellular Localization: To confirm UBP12’s presence in cytoplasmic and nuclear compartments via immunofluorescence .
Deubiquitination Activity: UBP12 cleaves K48/K63-linked ubiquitin chains. Catalytic inactivity (C208S mutation) abolishes its function, as shown in rescue experiments .
Redundancy with UBP13: Both enzymes share substrates (e.g., BRI1, ZTL) and exhibit overlapping phenotypes in mutants .
Further studies using UBP12-specific antibodies could:
Map temporal-spatial expression of UBP12 during development.
Identify novel interactors in stress response pathways.
Validate therapeutic targets in crop improvement (e.g., drought tolerance).